Diabetes Clinical Trials in Washington

Showing 221-240 of 334 trials

Adult Accuracy Study of the Enlite 3 Glucose Sensor

NCT02246582

The purpose of this study is to demonstrate the performance of the Enlite 3 Sensor over 168 hours (7 days) when inserted in the abdomen and used with the Guardian Mobile App and 640G Pump in subjects aged 14-75 years with type 1 or type 2 diabetes.

Type 1 DiabetesType 2 Diabetes

Medtronic MiniMed, Inc.118 participantsStarted Sep 2014

Escondido, California, United States • Walnut Creek, California, United States • Aurora, Colorado, United States +3 more locations

COMPLETEDPhase 336 miles

Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes

NCT00859898

The primary purpose of this study is to compare the change from baseline in hemoglobin A1C achieved with dapagliflozin 10 mg in combination with metformin XR as compared with metformin XR monotherapy and compared with Dapagliflozin monotherapy, after 24 weeks of oral administration of double-blind treatment. The safety of treatment with dapagliflozin will also be assessed in this study

Type 2 Diabetes Mellitus

AstraZeneca1,093 participantsStarted Apr 2009

Ozark, Alabama, United States • Tempe, Arizona, United States • Tempe, Arizona, United States +120 more locations

Adult Accuracy Study of the Enlite 3 Glucose Sensor

Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes

Diabetes Trials in Other Cities

Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin

Diet and Metabolic Inflammation

Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control

T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.

BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine

A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes

Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic Therapy

A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes

Efficacy of SYR-472 in Subjects With Type 2 Diabetes Mellitus

A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.

A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin

Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes

Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes

Other Conditions in Washington